HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Joëlle Nortier Selected Research

Diethylpropion (Amfepramone)

5/2003High prevalence of fenfluramine-related aortic regurgitation in women with end-stage renal disease secondary to Chinese herb nephropathy.
3/2002Progression rate of Chinese herb nephropathy: impact of Aristolochia fangchi ingested dose.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Joëlle Nortier Research Topics

Disease

8Fibrosis (Cirrhosis)
10/2022 - 11/2002
4Acute Kidney Injury (Acute Renal Failure)
01/2017 - 04/2015
3Neoplasms (Cancer)
06/2022 - 12/2014
3Chronic Kidney Failure (Chronic Renal Failure)
01/2016 - 03/2002
2Chronic Renal Insufficiency
06/2022 - 01/2017
2Wounds and Injuries (Trauma)
01/2017 - 01/2016
2Necrosis
01/2016 - 01/2016
2Urologic Neoplasms (Urological Cancer)
12/2015 - 05/2015
2Renal Insufficiency (Renal Failure)
09/2011 - 03/2002
1Fistula
01/2022
1Arteriovenous Fistula
01/2022
1Endocarditis
01/2022
1Heart Valve Diseases (Valvular Heart Disease)
01/2022
1Hypoxia (Hypoxemia)
06/2020
1Atrophy
06/2020
1Balkan Nephropathy (Balkan Endemic Nephropathy)
01/2017
1Interstitial Nephritis (Tubulointerstitial Nephritis)
01/2017
1Autoimmune Diseases (Autoimmune Disease)
01/2016
1Polyuria
01/2016
1Proteinuria
01/2016
1Membranous Glomerulonephritis (Membranous Nephropathy)
01/2016
1Peritoneal Fibrosis
12/2015
1Tuberculosis (Tuberculoses)
01/2013
1Uremia
09/2012
1Inflammation (Inflammations)
09/2012
1Cardiovascular Diseases (Cardiovascular Disease)
09/2012
1Carcinoma in Situ
03/2008
1Carcinoma (Carcinomatosis)
03/2008
1Aortic Valve Insufficiency (Aortic Regurgitation)
05/2003
1Body Weight (Weight, Body)
04/2003

Drug/Important Bio-Agent (IBA)

9aristolochic acid I (aristolochic acid)IBA
06/2022 - 04/2003
6Aristolochic AcidsIBA
10/2022 - 03/2002
3Cisplatin (Platino)FDA LinkGeneric
07/2015 - 12/2014
3Pharmaceutical PreparationsIBA
07/2015 - 03/2002
3FenfluramineIBA
05/2003 - 03/2002
2Drinking WaterIBA
01/2017 - 01/2016
2Diethylpropion (Amfepramone)FDA LinkGeneric
05/2003 - 03/2002
2SteroidsIBA
11/2002 - 03/2002
1Environmental Pollutants (Pollutants, Environmental)IBA
06/2022
1Methicillin (Metin)FDA Link
01/2022
1LignansIBA
01/2016
1Hexosaminidases (Hexosaminidase)IBA
01/2016
1Immunoglobulin D (IgD)IBA
01/2016
1AutoantibodiesIBA
01/2016
1Nitric Oxide (Nitrogen Monoxide)FDA Link
01/2016
1SodiumIBA
01/2016
1Biomarkers (Surrogate Marker)IBA
01/2016
1Annexin A5IBA
01/2016
1Nitric Oxide Synthase (NO Synthase)IBA
01/2016
1NADPH Oxidase 2IBA
01/2016
1Phospholipase A2 ReceptorsIBA
01/2016
1CreatinineIBA
01/2016
1EverolimusFDA Link
12/2015
1CollagenIBA
04/2015
1CateninsIBA
04/2015
1Alkylating AgentsIBA
12/2014
1Heparin (Liquaemin)FDA LinkGeneric
01/2013
13-chlorotyrosineIBA
09/2012
1Proteins (Proteins, Gene)FDA Link
09/2012
1VaccinesIBA
09/2011
1Hepatitis B Vaccines (Hepatitis B Vaccine)IBA
09/2011
1Appetite Depressants (Anorectics)IBA
05/2003
1SaltsIBA
04/2003

Therapy/Procedure

3Renal Dialysis (Hemodialysis)
01/2022 - 09/2012
2Transplantation
01/2016 - 09/2012
1Catheters
01/2022
1Nephroureterectomy
03/2008
1Kidney Transplantation
03/2008
1Subcutaneous Injections
04/2003
1Therapeutics
11/2002